A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

被引：0
|
作者：
Martin E Stryjewski
Arnold Lentnek
William O’Riordan
John Pullman
Paul Anantharajah Tambyah
Jose M Miró
Vance G Fowler Jr
Steven L Barriere
Michael M Kitt
G Ralph Corey
机构：
[1] Centro de Educación Médica e Investigaciones Clinicas (CEMIC) “Norberto Quirno”,Department of Medicine, Division of Infectious Diseases
[2] Wellstar Infectious Disease,Department of Medicine
[3] Mercury Street Medical Group,Infectious Diseases Service
[4] National University Health System,Department of Medicine, Division of Infectious Diseases
[5] Hospital Clinic–Institut d’investigacions Biomèdiques August Pi i Sunyer,undefined
[6] University of Barcelona,undefined
[7] Duke Clinical Research Institute,undefined
[8] Duke University Medical Center,undefined
[9] Theravance,undefined
[10] Inc,undefined
来源：
BMC Infectious Diseases | / 14卷
关键词：
Bacteremia; Telavancin; Vancomycin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A RANDOMIZED PHASE II TRIAL TO COMPARE THE EFFICACY OF STANDARD VERSUS COMBINATION THERAPY (PERAMPANEL, MEMANTINE PLUS STANDARD) IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GBM-A STUDY DESIGN
    Kong, Xiao-Tang
    Albala, Bruce
    Du, Senxi
    Kong, Xiao-Tang
    Bota, Daniela
    NEURO-ONCOLOGY, 2020, 22 : 194 - 194
  • [32] Randomized controlled trial of honey versus mupirocin to decolonize patients with nasal colonization of meticillin-resistant Staphylococcus aureus
    Poovelikunnel, T. T.
    Gethin, G.
    Solanki, D.
    McFadden, E.
    Codd, M.
    Humphreys, H.
    JOURNAL OF HOSPITAL INFECTION, 2018, 98 (02) : 141 - 148
  • [33] Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia
    Weems, J. John, Jr.
    Steinberg, James P.
    Filler, Scott
    Baddley, John W.
    Corey, G. Ralph
    Sampathkumar, Priya
    Winston, Lisa
    John, Joseph F.
    Kubin, Christine J.
    Talwani, Rohit
    Moore, Thomas
    Patti, Joseph M.
    Hetherington, Seth
    Texter, Michele
    Wenzel, Eric
    Kelley, Violet A.
    Fowler, Vance G., Jr.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2751 - 2755
  • [34] Combination of Antistaphylococcal β-Lactam With Standard Therapy Compared to Standard Therapy Alone for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the CAMERA2 Trial Using a Desirability of Outcome Ranking Approach
    Petersiel, Neta
    Davis, Joshua S.
    Meagher, Niamh
    Price, David J.
    Tong, Steven Y. C.
    Lye, David C.
    Yahav, Dafna
    Sud, Archana
    Robinson, J. Owen
    Nelson, Jane
    Archuleta, Sophia
    Roberts, Matthew A.
    Cass, Alan
    Paterson, David L.
    Foo, Hong
    Paul, Mical
    Guy, Stephen D.
    Tramontana, Adrian R.
    Walls, Genevieve B.
    Mcbride, Stephen
    Bak, Narin
    Ghosh, Niladri
    Rogers, Benjamin A.
    Ralph, Anna P.
    Davies, Jane
    Ferguson, Patricia E.
    Dotel, Ravindra
    Mckew, Genevieve L.
    Gray, Timothy J.
    Holmes, Natasha E.
    Smith, Simon
    Warner, Morgyn S.
    Kalimuddin, Shirin
    Young, Barnaby E.
    Runnegar, Naomi
    Andresen, David N.
    Anagnostou, Nicholas A.
    Johnson, Sandra A.
    Chatfield, Mark D.
    Cheng, Allen C.
    Fowler, Vance G.
    Howden, Benjamin P.
    Meagher, Niamh
    Price, David J.
    van Hal, Sebastiaan J.
    Sullivan, Matthew V. N. O.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (05):
  • [35] Treatment ambulance based on a community of Staphylococcus aureus bacteremias with or without endocarditis: Randomized analysis of a clinical trial comparing daptomycin with standard therapy
    Gonzalez Ramallo, Victor Jose
    REVISTA CLINICA ESPANOLA, 2010, 210 (01): : 41 - 41
  • [36] Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study
    Dong Hyun Oh
    Jung Ju Kim
    Jinnam Kim
    Hye Seong
    Se Ju Lee
    Yong Chan Kim
    Eun Jin Kim
    In Young Jung
    Woo Yong Jeong
    Su Jin Jeong
    Nam Su Ku
    Sang Hoon Han
    Jun Yong Choi
    Young Goo Song
    June Myung Kim
    BMC Infectious Diseases, 18
  • [37] Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study
    Oh, Dong Hyun
    Kim, Jung Ju
    Kim, Jinnam
    Seong, Hye
    Lee, Se Ju
    Kim, Yong Chan
    Kim, Eun Jin
    Jung, In Young
    Jeong, Woo Yong
    Jeong, Su Jin
    Ku, Nam Su
    Han, Sang Hoon
    Choi, Jun Yong
    Song, Young Goo
    Kim, June Myung
    BMC INFECTIOUS DISEASES, 2018, 18
  • [38] Randomized phase II study of axitinib versus standard of care in patients with recurrent glioblastoma
    Neyns, Bart
    Duerinck, Johnny
    Du Four, Stephanie
    Bouttens, Frank
    Verschaeve, Vincent
    Everaert, Hendrik
    Van Blnst, An
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima, Kenji
    Itoh, Hiroshi
    Kanazawa, Nobuaki
    Komuro, Issei
    Nagai, Ryozo
    Takeuchi, Masahiro
    Yamazaki, Tsutomu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (08) : 976 - 990
  • [40] Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment:: a prospective and randomized clinical trial of 381 patients
    Ruotsalainen, E
    Järvinen, A
    Koivula, I
    Kauma, H
    Rintala, E
    Lumio, J
    Kotilainen, P
    Vaara, M
    Nikoskelainen, J
    Valtonen, V
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (02) : 179 - 190
12345